Phase I Clinical Trials of Anticancer Agents

Ozols, Robert F.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project--Cooperative Agreements (U01)
• Project #: 5U01CA070024-02
• Application #: 2113980
• Study Section: Special Emphasis Panel (NSS)
• Project Start: 1995-05-19
• Project End: 1998-02-28
• Budget Start: 1996-05-02
• Budget End: 1997-02-28
• Support Year: 2
• Fiscal Year: 1996

Institution

• Name: Fox Chase Cancer Center
• DUNS #: 042250712
• City: Philadelphia
• State: PA
• Country: United States
• Zip Code: 19111

Publications

Schilder, R J; Gallo, J M; Millenson, M M et al. (2001) Phase I trial of multiple cycles of high-dose carboplatin, paclitaxel, and topotecan with peripheral-blood stem-cell support as front-line therapy. J Clin Oncol 19:1183-94

Hudes, G R; Szarka, C E; Adams, A et al. (2000) Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies. Clin Cancer Res 6:3071-80